In other studies, IL21R-AS1 was reported as a candidate coronary artery disease biomarker (Cai et al., 2016) and as an immune-related lncRNA predicting cervical squamous cell carcinoma prognosis (Lv et al., 2022). The gene discussed is IL21R; the disease is coronary artery disorder.